Latest Articles
It has been revealed why the recurrence rate of endometrial cancer, one of the representative female.. - 매일경제
It has been revealed why the recurrence rate of endometrial cancer, one of the representative female.. 매일경제
Published: May 20, 2026, 4:30 a.m.
‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected - SurvivorNet
‘Actress Amy Schumer, 44, Recent Colonoscopy Helps Reduce Cancer Risks By Wiping Out Precancerous Polyps Proactively, But She Says Her Procedure Left Her Recovering Longer Than Expected SurvivorNet
Published: May 19, 2026, 9:40 p.m.
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial - TipRanks
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial TipRanks
Published: May 19, 2026, 4:44 p.m.
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study - Yahoo Finance
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study Yahoo Finance
Published: May 19, 2026, 3:47 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times
Published: May 19, 2026, 3:15 p.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView
Published: May 19, 2026, 2 p.m.
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace
Published: May 19, 2026, 11:19 a.m.
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer - Indian Pharma Post
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer Indian Pharma Post
Published: May 19, 2026, 9:08 a.m.
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz
Published: May 19, 2026, 6:54 a.m.
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus
Published: May 18, 2026, 11:38 p.m.
Link copied to clipboard!